Tag: NASDAQ:DARE

December 11, 2019

Dare Biosciences and FDA Align on Phase 2b Study Design of Sildenafil

The company announced that it and the US Food and Drug Administration have reached an alignment for its Phase 2b...
May 8, 2019

Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1

Dare Bioscience (NASDAQ:DARE) has announced the publication of an article “Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in...
July 11, 2018

Biotech Update: Q2 2018 in Review

At the halfway mark of the year and with Q2 officially behind us, the Investing News Network takes a look...